Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Toxicity of cuprizone a Cu(2+) chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction.
Editorial: Glial Cells: Managers of Neuro-Immunity.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Sharing data from MS clinical trials: Opportunities, challenges, and future directions.
Microglia-derived IL-1β triggers p53-mediated cell cycle arrest and apoptosis in neural precursor cells.
Retinal nerve fiber layer thickness and neurologic disability in relapsing-remitting multiple sclerosis.
Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes.
Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
Efficacy of Schwann Cell (SC) transplantation for spinal cord repair is improved with combinatorial strategies.
Learning to swim, again: Axon regeneration in fish.
Risk factors of early onset of MS in women in reproductive age period: survival analysis approach.
Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes.
Gyroscopic corrections improve wearable sensor data prior to measuring dynamic sway in the gait of people with Multiple Sclerosis.
Demyelinating and thrombotic diseases of the central nervous system: common pathogenic and triggering factors.
Postnatal lethality and abnormal development of foregut and spleen in Ndrg4 mutant mice.
Alemtuzumab for multiple sclerosis.
Modulation of oligodendrocyte differentiation and maturation by combined biochemical and mechanical cues.
Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development.
12 Weeks of Combined Endurance and Resistance Training Reduces Innate Markers of Inflammation in a Randomized Controlled Clinical Trial in Patients with Multiple Sclerosis.
Evolution of rapid nerve conduction.
High prevalence of abnormal gastrointestinal permeability in moderate-severe asthma.
Lifestyle shapes the dialog between environment, microglia, and adult neurogenesis.
Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran.
Patient-specific early classification of multivariate observations.
Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Pages
« first
‹ previous
…
667
668
669
670
671
672
673
674
675
…
next ›
last »